跳至主要内容
临床试验/NCT01065714
NCT01065714已完成4 期

Transepidermal Water Loss (TEWL) and Corneometry With Hydrogel Vehicle in the Treatment of Atopic Dermatitis - A Randomized, Investigator-Blind Pilot Study

Derm Research, PLLC1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2010年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
20
试验地点
1
主要终点
Percent Change of Trans Epidermal Water Loss (TEWL) With Use of Eucerin Lotion

研究概览

简要总结

While the repair of the epidermal barrier in atopic dermatitis is of major importance in the treatment of atopic dermatitis, most of the vehicles used may actually cause a worsening of an impaired epidermal barrier. Hydrogel vehicle is anecdotally known to be moisturizing and hydrating.This study will compare the use of Hydrogel vehicle and Eucerin Lotion in maintaining the epidermal barrier in subjects with atopic dermatitis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Definitive diagnosis of atopic dermatitis as characterized by Hanifin and Rajka criteria:
  • 3 out of 4 major characteristics
  • At least 3 minor characteristics
  • Mild to moderate disease score of 2 or 3 by Investigator Global Assessment
  • Minimum 5% Body Surface Area at Baseline
  • Uniformly bilateral signs and symptoms of atopic dermatitis
  • Able to understand and comply with the requirements of the study and sign Informed Consent/HIPAA forms. Subjects under the legal age of consent must also have written informed consent of the parent or legal guardian.

排除标准

  • Allergy or sensitivity to any component of the test articles.
  • Subjects who have not complied with the proper washout periods for prohibited medications.
  • Significant coagulation disorder or any medical condition that, in the opinion of the investigator, contraindicates the subject's participation in the study.
  • Recent alcohol or drug abuse is evident.
  • History of poor cooperation, non-compliance with medical treatment or unreliability
  • Participation in an investigational drug study within 30 days of the Baseline Visit.

研究组 & 干预措施

Hydrogel vehicle

Experimental

Parallel designed study. Split body treatment

干预措施: Hydrogel vehicle (Drug)

Eucerin Lotion

Active Comparator

Parallel study design. Split body study.

干预措施: Eucerin Lotion (Drug)

结局指标

主要结局

Percent Change of Trans Epidermal Water Loss (TEWL) With Use of Eucerin Lotion

时间窗: Day 1 to Day 14

The average of three sequential Tewameter 300 meter readings taken at a minimum of one minute intervals on targeted area of body half treated with Eucerin lotion

Percent Change of Trans Epidural Water Loss (TEWL) With the Use of Hydrogel Vehicle

时间窗: Day 1 to Day 14

The average of three sequential Tewameter 300 meter readings taken at a minimum of one minute intervals on target areas of body half treated with Hydrogel vehicle

次要结局

  • Percentage of Participants With an Increase in Skin Hydration Using Eucerin Lotion on Targeted Area on One Half of Body(Baseline to 14 days)
  • Percentage of Participants With an Increase in Skin Hydration Using Hydrogel Vehicle on Targeted Area of One Half of Body.(Baseline to 14 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Leon Kircik, M.D.

Principal Investigator

Derm Research, PLLC

研究点 (1)

Loading locations...

相似试验

A Study to Investigate the Use of Hydrogel Vehicle... | 临床试验